| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression | 22 | 2017 | 380 | 4.740 |
Why?
|
| Macaca fascicularis | 45 | 2019 | 389 | 4.170 |
Why?
|
| Sertraline | 8 | 2017 | 27 | 3.840 |
Why?
|
| Serotonin Uptake Inhibitors | 9 | 2017 | 35 | 3.310 |
Why?
|
| Behavior, Animal | 16 | 2015 | 264 | 2.950 |
Why?
|
| Stress, Psychological | 18 | 2015 | 208 | 2.660 |
Why?
|
| Disease Models, Animal | 31 | 2018 | 980 | 2.420 |
Why?
|
| Depressive Disorder | 7 | 2016 | 74 | 2.270 |
Why?
|
| Animals | 81 | 2020 | 7297 | 2.140 |
Why?
|
| Diet, Mediterranean | 4 | 2019 | 23 | 1.700 |
Why?
|
| Aging | 10 | 2017 | 881 | 1.470 |
Why?
|
| Coronary Artery Disease | 8 | 2015 | 359 | 1.440 |
Why?
|
| Hippocampus | 6 | 2016 | 185 | 1.400 |
Why?
|
| Motor Activity | 7 | 2016 | 310 | 1.330 |
Why?
|
| Social Behavior | 8 | 2013 | 67 | 1.330 |
Why?
|
| Antidepressive Agents | 4 | 2017 | 70 | 1.290 |
Why?
|
| Female | 73 | 2019 | 18164 | 1.250 |
Why?
|
| Primates | 10 | 2019 | 100 | 1.230 |
Why?
|
| Monkey Diseases | 3 | 2014 | 18 | 0.990 |
Why?
|
| Ovariectomy | 10 | 2018 | 147 | 0.970 |
Why?
|
| Obesity | 7 | 2019 | 1063 | 0.970 |
Why?
|
| Hydrocortisone | 10 | 2013 | 61 | 0.870 |
Why?
|
| Aggression | 8 | 2007 | 29 | 0.860 |
Why?
|
| Heart Rate | 8 | 2017 | 315 | 0.850 |
Why?
|
| Energy Metabolism | 3 | 2019 | 139 | 0.830 |
Why?
|
| Random Allocation | 10 | 2018 | 213 | 0.820 |
Why?
|
| Postmenopause | 5 | 2011 | 397 | 0.820 |
Why?
|
| Progesterone | 8 | 2014 | 80 | 0.820 |
Why?
|
| Ethanol | 6 | 2007 | 185 | 0.770 |
Why?
|
| Hierarchy, Social | 7 | 2013 | 24 | 0.760 |
Why?
|
| Estradiol | 5 | 2018 | 118 | 0.760 |
Why?
|
| Atherosclerosis | 5 | 2015 | 693 | 0.760 |
Why?
|
| Dominance-Subordination | 9 | 2005 | 15 | 0.750 |
Why?
|
| Premenopause | 2 | 2017 | 38 | 0.750 |
Why?
|
| Soybeans | 2 | 2014 | 25 | 0.730 |
Why?
|
| Muscle, Skeletal | 4 | 2019 | 494 | 0.720 |
Why?
|
| Isoflavones | 2 | 2014 | 65 | 0.720 |
Why?
|
| Carotid Artery Diseases | 2 | 2017 | 109 | 0.690 |
Why?
|
| Neurons | 3 | 2013 | 394 | 0.690 |
Why?
|
| Brain | 7 | 2018 | 930 | 0.680 |
Why?
|
| Heart | 3 | 2018 | 161 | 0.670 |
Why?
|
| Mammary Glands, Human | 1 | 2018 | 15 | 0.670 |
Why?
|
| Fatty Liver | 1 | 2019 | 66 | 0.670 |
Why?
|
| Energy Intake | 1 | 2019 | 120 | 0.670 |
Why?
|
| Haplorhini | 6 | 2019 | 64 | 0.650 |
Why?
|
| Carotid Artery, Common | 1 | 2017 | 37 | 0.620 |
Why?
|
| Alcohol Drinking | 4 | 2004 | 244 | 0.600 |
Why?
|
| Synapses | 2 | 2017 | 85 | 0.590 |
Why?
|
| Endotoxemia | 1 | 2016 | 8 | 0.570 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 64 | 0.550 |
Why?
|
| Housing, Animal | 2 | 2014 | 23 | 0.540 |
Why?
|
| Sarcopenia | 1 | 2016 | 53 | 0.530 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 5 | 0.510 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2007 | 182 | 0.510 |
Why?
|
| Animals, Laboratory | 1 | 2014 | 4 | 0.500 |
Why?
|
| Serotonin | 5 | 2004 | 35 | 0.500 |
Why?
|
| Adipose Tissue | 4 | 2016 | 327 | 0.490 |
Why?
|
| Soybean Proteins | 1 | 2014 | 64 | 0.490 |
Why?
|
| Dentate Gyrus | 1 | 2014 | 6 | 0.490 |
Why?
|
| Myocardium | 2 | 2018 | 170 | 0.490 |
Why?
|
| Biogenic Monoamines | 1 | 2013 | 4 | 0.480 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2014 | 26 | 0.480 |
Why?
|
| Neuroglia | 1 | 2014 | 29 | 0.480 |
Why?
|
| Social Isolation | 3 | 2013 | 42 | 0.470 |
Why?
|
| Hemorrhage | 1 | 2014 | 90 | 0.470 |
Why?
|
| Neuropil | 1 | 2013 | 2 | 0.460 |
Why?
|
| Cholesterol | 3 | 2011 | 229 | 0.460 |
Why?
|
| Imitative Behavior | 1 | 2013 | 2 | 0.460 |
Why?
|
| Dexamethasone | 6 | 2013 | 42 | 0.440 |
Why?
|
| Body Composition | 5 | 2019 | 365 | 0.440 |
Why?
|
| Cardiovascular Diseases | 4 | 2019 | 1013 | 0.440 |
Why?
|
| Coronary Vessels | 2 | 2015 | 147 | 0.440 |
Why?
|
| Photic Stimulation | 1 | 2013 | 155 | 0.430 |
Why?
|
| Analysis of Variance | 6 | 2017 | 454 | 0.430 |
Why?
|
| Fatty Acids | 2 | 2019 | 92 | 0.420 |
Why?
|
| Hydroxyindoleacetic Acid | 4 | 2015 | 17 | 0.410 |
Why?
|
| Nervous System | 1 | 2011 | 15 | 0.410 |
Why?
|
| Social Environment | 3 | 2020 | 75 | 0.410 |
Why?
|
| Risk Factors | 11 | 2017 | 3531 | 0.400 |
Why?
|
| Gait | 1 | 2011 | 115 | 0.390 |
Why?
|
| Women's Health | 2 | 2009 | 226 | 0.380 |
Why?
|
| Adaptation, Biological | 1 | 2009 | 8 | 0.360 |
Why?
|
| Macaca | 8 | 2015 | 25 | 0.360 |
Why?
|
| Lipids | 1 | 2011 | 209 | 0.350 |
Why?
|
| Pituitary-Adrenal System | 6 | 2008 | 24 | 0.340 |
Why?
|
| Medroxyprogesterone Acetate | 2 | 2007 | 89 | 0.340 |
Why?
|
| Hypothalamo-Hypophyseal System | 6 | 2008 | 34 | 0.340 |
Why?
|
| Intra-Abdominal Fat | 1 | 2009 | 61 | 0.340 |
Why?
|
| Ovary | 5 | 2014 | 54 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 118 | 0.330 |
Why?
|
| Humans | 25 | 2020 | 29093 | 0.320 |
Why?
|
| Heart Failure | 1 | 2014 | 568 | 0.320 |
Why?
|
| Estrogens | 7 | 2013 | 162 | 0.310 |
Why?
|
| Arousal | 3 | 2005 | 19 | 0.290 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2006 | 4 | 0.280 |
Why?
|
| Central Nervous System Depressants | 1 | 2007 | 63 | 0.280 |
Why?
|
| Menopause | 4 | 2013 | 86 | 0.280 |
Why?
|
| Alcoholism | 1 | 2007 | 95 | 0.280 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 720 | 0.270 |
Why?
|
| Cell Count | 2 | 2013 | 50 | 0.270 |
Why?
|
| Dopamine | 2 | 1998 | 226 | 0.260 |
Why?
|
| Positron-Emission Tomography | 1 | 2006 | 172 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2016 | 1218 | 0.250 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 46 | 0.250 |
Why?
|
| Ethinyl Estradiol-Norgestrel Combination | 1 | 2004 | 3 | 0.240 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2004 | 7 | 0.240 |
Why?
|
| Mood Disorders | 1 | 2004 | 19 | 0.240 |
Why?
|
| Contraceptives, Oral | 1 | 2004 | 20 | 0.240 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2004 | 28 | 0.240 |
Why?
|
| Body Mass Index | 4 | 2013 | 865 | 0.230 |
Why?
|
| Endometrium | 1 | 2004 | 120 | 0.230 |
Why?
|
| Object Attachment | 1 | 2002 | 2 | 0.220 |
Why?
|
| Plant Preparations | 1 | 2003 | 21 | 0.220 |
Why?
|
| Organ Size | 2 | 2015 | 196 | 0.220 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 34 | 0.220 |
Why?
|
| Cytokines | 2 | 2015 | 243 | 0.220 |
Why?
|
| Longevity | 2 | 2020 | 22 | 0.220 |
Why?
|
| Alzheimer Disease | 2 | 2018 | 312 | 0.220 |
Why?
|
| Cognition | 2 | 2004 | 526 | 0.210 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 113 | 0.210 |
Why?
|
| Administration, Oral | 2 | 2015 | 169 | 0.200 |
Why?
|
| Diet | 3 | 2014 | 354 | 0.200 |
Why?
|
| Placebos | 2 | 2014 | 61 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2015 | 153 | 0.190 |
Why?
|
| Mammals | 1 | 2020 | 9 | 0.190 |
Why?
|
| Inflammation | 3 | 2015 | 507 | 0.190 |
Why?
|
| Diet, Atherogenic | 3 | 2013 | 61 | 0.180 |
Why?
|
| Receptors, Dopamine D2 | 2 | 1998 | 80 | 0.180 |
Why?
|
| Mitochondria, Muscle | 1 | 2019 | 17 | 0.180 |
Why?
|
| Comorbidity | 2 | 2014 | 540 | 0.180 |
Why?
|
| Gene Expression | 2 | 2018 | 332 | 0.180 |
Why?
|
| Health Status | 1 | 2002 | 368 | 0.180 |
Why?
|
| Contraceptives, Oral, Sequential | 1 | 1998 | 1 | 0.170 |
Why?
|
| Treatment Outcome | 2 | 2017 | 3099 | 0.170 |
Why?
|
| Diastole | 1 | 2018 | 90 | 0.160 |
Why?
|
| Male | 13 | 2017 | 17807 | 0.160 |
Why?
|
| Time Factors | 5 | 2018 | 2001 | 0.160 |
Why?
|
| Carrier Proteins | 3 | 2006 | 131 | 0.160 |
Why?
|
| Homeostasis | 1 | 2018 | 127 | 0.160 |
Why?
|
| Vagus Nerve | 1 | 2017 | 29 | 0.160 |
Why?
|
| Equilin | 1 | 1997 | 1 | 0.150 |
Why?
|
| Anxiety | 2 | 2015 | 159 | 0.150 |
Why?
|
| Dendrites | 1 | 1997 | 15 | 0.150 |
Why?
|
| Circadian Rhythm | 3 | 2013 | 43 | 0.150 |
Why?
|
| Reference Values | 1 | 2017 | 224 | 0.150 |
Why?
|
| Lewy Body Disease | 1 | 2017 | 5 | 0.150 |
Why?
|
| Inheritance Patterns | 1 | 2017 | 10 | 0.150 |
Why?
|
| Nerve Degeneration | 1 | 2017 | 10 | 0.150 |
Why?
|
| Hot Flashes | 1 | 2017 | 46 | 0.150 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2014 | 37 | 0.150 |
Why?
|
| Neostriatum | 1 | 2017 | 21 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2019 | 449 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 226 | 0.150 |
Why?
|
| Apolipoprotein E4 | 1 | 2017 | 58 | 0.150 |
Why?
|
| Calcium | 1 | 2018 | 296 | 0.150 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2005 | 22 | 0.150 |
Why?
|
| Bacterial Translocation | 1 | 2016 | 8 | 0.140 |
Why?
|
| Atlases as Topic | 1 | 2016 | 9 | 0.140 |
Why?
|
| Phenotype | 3 | 2015 | 629 | 0.140 |
Why?
|
| Intestines | 1 | 2016 | 54 | 0.140 |
Why?
|
| Menstrual Cycle | 4 | 2002 | 36 | 0.140 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2015 | 3 | 0.130 |
Why?
|
| Menisci, Tibial | 1 | 2015 | 24 | 0.130 |
Why?
|
| Brain Mapping | 1 | 2016 | 182 | 0.130 |
Why?
|
| Iliac Artery | 1 | 2015 | 46 | 0.130 |
Why?
|
| Triiodothyronine | 1 | 2014 | 7 | 0.130 |
Why?
|
| Thyrotropin | 1 | 2014 | 9 | 0.130 |
Why?
|
| Lactalbumin | 1 | 2014 | 10 | 0.130 |
Why?
|
| Caseins | 1 | 2014 | 13 | 0.130 |
Why?
|
| Thyroxine | 1 | 2014 | 16 | 0.130 |
Why?
|
| Thyroid Gland | 1 | 2014 | 13 | 0.130 |
Why?
|
| Upper Extremity | 1 | 2015 | 52 | 0.130 |
Why?
|
| Rotator Cuff | 1 | 2015 | 67 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2015 | 80 | 0.130 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 21 | 0.130 |
Why?
|
| Dietary Proteins | 1 | 2014 | 50 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 32 | 0.120 |
Why?
|
| Models, Animal | 4 | 2016 | 160 | 0.120 |
Why?
|
| Body Weights and Measures | 1 | 2014 | 22 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2013 | 165 | 0.120 |
Why?
|
| Knee Joint | 1 | 2015 | 129 | 0.120 |
Why?
|
| Microfilament Proteins | 1 | 2014 | 33 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2015 | 130 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 242 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 1379 | 0.120 |
Why?
|
| Geriatrics | 1 | 2015 | 94 | 0.120 |
Why?
|
| Vision, Ocular | 1 | 2013 | 30 | 0.120 |
Why?
|
| Body Weight | 2 | 2016 | 290 | 0.120 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 11 | 0.120 |
Why?
|
| Stereotaxic Techniques | 1 | 2013 | 23 | 0.120 |
Why?
|
| Echocardiography | 1 | 2014 | 140 | 0.120 |
Why?
|
| Receptors, Bombesin | 1 | 2013 | 8 | 0.110 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2013 | 7 | 0.110 |
Why?
|
| Nerve Fibers | 1 | 2013 | 30 | 0.110 |
Why?
|
| Steroids | 1 | 2013 | 36 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 129 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 641 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2013 | 100 | 0.110 |
Why?
|
| Sex Factors | 3 | 2014 | 631 | 0.110 |
Why?
|
| Aged | 5 | 2017 | 9487 | 0.110 |
Why?
|
| Video Recording | 1 | 2013 | 52 | 0.110 |
Why?
|
| Pruritus | 1 | 2013 | 58 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2013 | 74 | 0.110 |
Why?
|
| Cercopithecidae | 1 | 2011 | 10 | 0.110 |
Why?
|
| Spinal Cord | 1 | 2013 | 139 | 0.100 |
Why?
|
| Neurobiology | 1 | 2011 | 3 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 104 | 0.100 |
Why?
|
| Macaca mulatta | 1 | 2013 | 322 | 0.100 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2011 | 14 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2108 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2011 | 106 | 0.100 |
Why?
|
| Anthropometry | 2 | 2009 | 82 | 0.100 |
Why?
|
| Shoulder Joint | 1 | 2013 | 123 | 0.100 |
Why?
|
| Hormone Replacement Therapy | 3 | 2010 | 86 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2013 | 422 | 0.090 |
Why?
|
| Cross-Over Studies | 2 | 2007 | 94 | 0.090 |
Why?
|
| Behavior | 1 | 2008 | 29 | 0.080 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2008 | 11 | 0.080 |
Why?
|
| Endometrial Hyperplasia | 1 | 2008 | 14 | 0.080 |
Why?
|
| Emotions | 1 | 2008 | 48 | 0.080 |
Why?
|
| Luteal Phase | 1 | 2008 | 22 | 0.080 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 19 | 0.080 |
Why?
|
| Blood Platelets | 1 | 2008 | 37 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2008 | 63 | 0.080 |
Why?
|
| Administration, Intravaginal | 1 | 2007 | 6 | 0.080 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2007 | 5 | 0.080 |
Why?
|
| Tomography, Emission-Computed | 2 | 1998 | 25 | 0.080 |
Why?
|
| Arteriosclerosis | 2 | 1998 | 116 | 0.080 |
Why?
|
| Telemetry | 1 | 2007 | 27 | 0.070 |
Why?
|
| Sympathetic Nervous System | 1 | 2007 | 29 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 391 | 0.070 |
Why?
|
| Autonomic Nervous System | 1 | 2007 | 42 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2010 | 390 | 0.070 |
Why?
|
| Radioligand Assay | 1 | 2006 | 23 | 0.070 |
Why?
|
| Gyrus Cinguli | 1 | 2006 | 22 | 0.070 |
Why?
|
| Pyridines | 1 | 2006 | 78 | 0.070 |
Why?
|
| Piperazines | 1 | 2006 | 56 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2006 | 56 | 0.070 |
Why?
|
| Insulin | 2 | 2019 | 346 | 0.070 |
Why?
|
| Amygdala | 1 | 2006 | 60 | 0.070 |
Why?
|
| Radiopharmaceuticals | 1 | 2006 | 87 | 0.070 |
Why?
|
| Physical Conditioning, Animal | 2 | 2017 | 32 | 0.070 |
Why?
|
| Estrus | 1 | 2005 | 5 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2003 | 281 | 0.060 |
Why?
|
| Social Dominance | 2 | 2011 | 18 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 836 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2004 | 10 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 97 | 0.060 |
Why?
|
| Endometrial Neoplasms | 1 | 2004 | 34 | 0.060 |
Why?
|
| Neurosecretory Systems | 1 | 2004 | 4 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 426 | 0.060 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2004 | 29 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2004 | 44 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2006 | 859 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2005 | 440 | 0.060 |
Why?
|
| Glucocorticoids | 2 | 2011 | 149 | 0.060 |
Why?
|
| Densitometry | 1 | 2003 | 8 | 0.060 |
Why?
|
| Pineal Gland | 1 | 2003 | 3 | 0.060 |
Why?
|
| Citalopram | 1 | 2003 | 5 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 14 | 0.060 |
Why?
|
| Phytoestrogens | 1 | 2003 | 16 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2003 | 22 | 0.060 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2003 | 16 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 3717 | 0.060 |
Why?
|
| Mesencephalon | 1 | 2003 | 18 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2003 | 30 | 0.060 |
Why?
|
| Stereotyped Behavior | 1 | 2002 | 14 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 97 | 0.050 |
Why?
|
| Rats | 2 | 2015 | 1604 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 90 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 1108 | 0.050 |
Why?
|
| Genetic Fitness | 1 | 2020 | 2 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2001 | 167 | 0.050 |
Why?
|
| Liver | 1 | 2003 | 464 | 0.050 |
Why?
|
| Raphe Nuclei | 1 | 2000 | 1 | 0.050 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2000 | 1 | 0.050 |
Why?
|
| Progestins | 1 | 2000 | 18 | 0.050 |
Why?
|
| Self Administration | 1 | 2001 | 296 | 0.050 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2019 | 6 | 0.050 |
Why?
|
| Growth Hormone | 1 | 1998 | 13 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 1998 | 30 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 519 | 0.040 |
Why?
|
| Middle Aged | 3 | 2015 | 10829 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 91 | 0.040 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 1999 | 125 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 1999 | 159 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 293 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 1998 | 60 | 0.040 |
Why?
|
| Pregnanolone | 1 | 1997 | 3 | 0.040 |
Why?
|
| Grooming | 1 | 1997 | 2 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2013 | 2019 | 0.040 |
Why?
|
| Homozygote | 1 | 2017 | 57 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 1997 | 20 | 0.040 |
Why?
|
| Autopsy | 1 | 2017 | 37 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 466 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2016 | 7 | 0.040 |
Why?
|
| Alleles | 1 | 2017 | 251 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2016 | 13 | 0.040 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2015 | 5 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2015 | 11 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 24 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 246 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 18 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 29 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 26 | 0.030 |
Why?
|
| Ketamine | 1 | 2015 | 20 | 0.030 |
Why?
|
| Metabolome | 1 | 2015 | 31 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 747 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 46 | 0.030 |
Why?
|
| Social Class | 1 | 2015 | 78 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2015 | 68 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 26 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 711 | 0.030 |
Why?
|
| Animal Experimentation | 1 | 2014 | 6 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 353 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2015 | 211 | 0.030 |
Why?
|
| United States | 2 | 2014 | 3630 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 31 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2013 | 39 | 0.030 |
Why?
|
| Leptin | 1 | 2013 | 66 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 36 | 0.030 |
Why?
|
| Astrocytes | 1 | 2013 | 49 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 129 | 0.030 |
Why?
|
| Temporal Lobe | 1 | 2013 | 41 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 355 | 0.030 |
Why?
|
| Isotonic Contraction | 1 | 2012 | 8 | 0.030 |
Why?
|
| Myofibrils | 1 | 2012 | 10 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2013 | 73 | 0.030 |
Why?
|
| Adiponectin | 1 | 2013 | 103 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2013 | 871 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 114 | 0.030 |
Why?
|
| RNA | 1 | 2013 | 88 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 67 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 481 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2012 | 86 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 177 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 141 | 0.030 |
Why?
|
| Macrophages | 1 | 2013 | 188 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2013 | 369 | 0.030 |
Why?
|
| Skin | 1 | 2013 | 203 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 795 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 81 | 0.020 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 2010 | 21 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2010 | 37 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2015 | 1131 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 289 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1362 | 0.020 |
Why?
|
| Mice | 1 | 2015 | 2368 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 896 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2008 | 30 | 0.020 |
Why?
|
| Hispanic Americans | 1 | 2015 | 904 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 298 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 366 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2008 | 97 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2008 | 103 | 0.020 |
Why?
|
| African Americans | 1 | 2015 | 1373 | 0.020 |
Why?
|
| Phylogeny | 1 | 2003 | 58 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2000 | 14 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2000 | 48 | 0.010 |
Why?
|
| Problem Solving | 1 | 1999 | 27 | 0.010 |
Why?
|
| Diet, Fat-Restricted | 1 | 1999 | 30 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1998 | 15 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1998 | 21 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 514 | 0.010 |
Why?
|
| Benzamides | 1 | 1998 | 54 | 0.010 |
Why?
|
| Piperidines | 1 | 1998 | 125 | 0.010 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 1996 | 1 | 0.010 |
Why?
|
| Causality | 1 | 1996 | 37 | 0.010 |
Why?
|
| Ovarian Diseases | 1 | 1996 | 8 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 532 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 1996 | 247 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 815 | 0.010 |
Why?
|